Novel Statistical Methods for Complex Time-to-Event Data in Cardiovascular Clinical Trials
Novel Statistical Methods for Complex Time-to-Event Data in Cardiovascular Clinical Trials
批准号:
10063907
负责人:
Lu Mao
金额:
$36.82万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-01 至 2022-11-30
关键词:
AddendumAddressAlgorithmsCardiopulmonaryCardiovascular DiseasesCardiovascular systemCessation of lifeChestChronicChronic DiseaseClinicalClinical TrialsComplexComplicationDataData Coordinating CenterDevelopmentDiagnosticDimensionsDiseaseDropoutEnrollmentEquationEquine muleEventFoundationsFrequenciesFundingGoalsGoldHeart failureHospitalizationIncidenceInfluenzaInvestigationLeadMethodologyMethodsModelingModernizationMyocardial InfarctionNational Heart, Lung, and Blood InstituteNatureNorth AmericaOutcomePartner in relationshipPatientsPrincipal InvestigatorProbabilityProceduresProcessProportional Hazards ModelsPublishingRandomizedRandomized Controlled TrialsRecurrenceResearch PersonnelRiskSamplingSeasonsSelection BiasStatistical MethodsStrokeSurvival AnalysisTestingTimeUniversitiesVaccinatedWeightWisconsinWorkarmbaseclinical trial analysisclinically relevantcohortcostdesigndosagefollow-uphazardinfluenza virus vaccinenon-compliancenovelpreventprimary endpointrandomized trialsemiparametricsoundsurvivorshiptheoriestooltreatment armtrial comparinguser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Many cardiovascular (CV) clinical trials feature complex composite outcomes consisting of multiple types of
(possibly recurrent) events, e.g., heart failure, myocardial infarction, stroke, and death. In addition, due to the
chronic nature of the disease, these long-term trials often suffer from non-randomized cohorts as a result of
informative dropout, a complication that shakes the foundation of randomized controlled trials as the gold
standard for clinical inquiry. Motivated by the INVESTED trial, an ongoing multi-season CV trial comparing two
dosages of influenza vaccine (for which we serve as lead statisticians), this proposal aims to develop novel
statistical methodology that is more robust, more efficient, and better suited for such long-term CV trials. This
goal will be achieved via three specific aims. For specific aim 1, we tackle the problem of non-randomized
cohort adjustment under a comprehensive framework of time-to-event analysis, including the well-known
Kaplan-Meier curve, log-rank test, Cox regression model, and other methods for recurrent events and
competing risks. We will develop a robust inverse probability of treatment weighting (IPTW) approach with non-
/semi-parametrically estimated weights to correct for selection bias in non-randomized cohorts. For specific
aim 2, we generalize the newly developed win-loss approach for composite outcomes from two-sample testing
to the regression setting. The win-loss approach is targeted for composite endpoints consisting of prioritized
components, e.g., death over non-fatal events. The information it extracts from multiple prioritized time-to-
event outcomes is fuller, more interpretable, and clinically more relevant than that contained in time to the first
event, the traditional target of analysis. For specific aim 3, we further generalize the win-loss approach to a
nonparametric framework that allows the win-loss probabilities to depend on the follow-up time. Both
generalizations of the win-loss approach will proceed in an estimand-driven way as recommended by the
recently published ICH-E9(R1) Addendum. Statistical efficiency of the proposed procedures will be studied
thoroughly using modern semiparametric and weak convergence theories. Development of efficient procedures
will help minimize trial costs. User-friendly R packages that implement the algorithms of the proposed methods
will be developed and disseminated through https://cran.r-project.org.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Statistical Methods for Complex Time-to-Event Data in Cardiovascular Clinical Trials
-
批准号:10311488
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2019
-
负责人:Lu Mao
-
依托单位:
Novel Statistical Methods for Complex Time-to-Event Data in Cardiovascular Clinical Trials
-
批准号:10734551
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2019
-
负责人:Lu Mao
-
依托单位:
海外基金